Raises $14 Million Series B Financing

DiscGenics Raises $14 Million in Series B Financing

SALT LAKE CITY, Sept. 26, 2017 /PRNewswire/ — DiscGenics, Inc., a clinical stage regenerative medicine company focused on developing regenerative therapies that alleviate…